Hematopoietic Malignancies Clinical Trials in Washington D.C., District of Columbia

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies